Inventor
BURNETT JR JOHN C
US36 patents
⚠️ This page may combine multiple inventors who share the name “BURNETT JR JOHN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAYO FOUNDATION
20 patentsUS6818619B2Nov 16, 2004
Chimeric natriuretic peptides
MAYO FOUNDATION101 citations98
US7754852B2Jul 13, 2010
Natriuretic polypeptides
MAYO FOUNDATION131 citations97
US7384917B2Jun 10, 2008
Chimeric natriuretic peptides
MAYO FOUNDATION58 citations97
US6407211B1Jun 18, 2002
Chimeric natriuretic peptides
MAYO FOUNDATION87 citations97
US7964564B2Jun 21, 2011
Chimeric natriuretic peptides
MAYO FOUNDATION16 citations92
US7803901B2Sep 28, 2010
Polypeptides with natriuresis activity
MAYO FOUNDATION37 citations91
US9102757B2Aug 11, 2015
Chimeric aquaretic and natriuretic polypeptides lacking vasodilatory activity
MAYO FOUNDATION7 citations83
US8357656B2Jan 22, 2013
Natriuretic peptide receptor-C agonists
MAYO FOUNDATION12 citations81
US8835601B2Sep 16, 2014
Natriuretic polypeptide delivery systems
MAYO FOUNDATION9 citations79
US9193777B2Nov 24, 2015
Method of treating cardiac arrhythmia with long acting atrial natriuretic peptide(LA-ANP)
MAYO FOUNDATION10 citations77
US9611305B2Apr 4, 2017
Treating cardiovascular or renal diseases
MAYO FOUNDATION3 citations70
US9587004B2Mar 7, 2017
Natriuretic polypeptides
MAYO FOUNDATION1 citations62
US9441027B2Sep 13, 2016
Natriuretic polypeptides
MAYO FOUNDATION1 citations62
US9365631B2Jun 14, 2016
Method of increasing natriuretic activity by administering natriuretic polypeptides with unique pharmacologic profiles
MAYO FOUNDATION1 citations62
US9115209B2Aug 25, 2015
Method of treatment of cardiovascular or renal conditions with natriuretic polypeptides with unique pharmacologic profiles
MAYO FOUNDATION1 citations62
US9132166B2Sep 15, 2015
Method of treatment of renal dysfunctions with chimeric natriuretic peptides
MAYO FOUNDATION1 citations61
US9771405B2Sep 26, 2017
Nucleic acids encoding for chimeric natriuretic polypeptides with unique pharmacologic profiles
MAYO FOUNDATION0 citations51
US9469682B2Oct 18, 2016
Methods of treatment using natriuretic polypeptides
MAYO FOUNDATION0 citations51
US9439951B2Sep 13, 2016
Methods of treatment of heart dysfunctions using diuretic and natriuretic polypeptides
MAYO FOUNDATION0 citations51
US9079973B2Jul 14, 2015
Natriuretic polypeptides for reducing restenosis
MAYO FOUNDATION1 citations51
MAYO FOUND MEDICAL EDUCATION & RES
8 patentsUS11072642B2Jul 27, 2021
MANP analogues
MAYO FOUND MEDICAL EDUCATION & RES1 citations73
US11897931B2Feb 13, 2024
MANP analogues
MAYO FOUND MEDICAL EDUCATION & RES0 citations62
US9857382B2Jan 2, 2018
Assessing renal structural alterations and outcomes
MAYO FOUND MEDICAL EDUCATION & RES2 citations62
US10344068B2Jul 9, 2019
Natriuretic polypeptides
MAYO FOUND MEDICAL EDUCATION & RES0 citations51
US10336803B2Jul 2, 2019
Insulin secreting polypeptides
MAYO FOUND MEDICAL EDUCATION & RES0 citations51
US9938334B2Apr 10, 2018
Insulin secreting polypeptides
MAYO FOUND MEDICAL EDUCATION & RES0 citations51
US10092628B2Oct 9, 2018
Treating cardiovascular or renal diseases
MAYO FOUND MEDICAL EDUCATION & RES0 citations49
US9987331B2Jun 5, 2018
Treating cardiovascular or renal diseases
MAYO FOUND MEDICAL EDUCATION & RES0 citations49
BURNETT JR JOHN C
3 patentsUS8455438B2Jun 4, 2013
Natriuretic polypeptides for reducing or preventing restenosis
BURNETT JR JOHN C16 citations90
US8063191B2Nov 22, 2011
Polynucleotides encoding for fusion proteins with natriuresis activity
BURNETT JR JOHN C16 citations90
US8741842B2Jun 3, 2014
Chimeric natriuretic polypeptides with unique pharmacologic profiles
BURNETT JR JOHN C11 citations82